Science Explorer Interactive view Map
Company · New Brunswick · United States

Bionex Pharmaceuticals (United States)

bionexpharma.comROR OpenAlex
Research works
1
fractional, all time
Citations
14
18.7 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
33%
world 28%

Not ranked overall: Bionex Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Bionex Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Nicotinic Acetylcholine Receptors Study, Vagus Nerve Stimulation Research and Smoking Behavior and Cessation.

Nicotinic Acetylcholine …0Nicotinic Acetylcholine Receptors Study: 0 fractional worksVagus Nerve Stimulation …0Vagus Nerve Stimulation Research: 0 fractional worksSmoking Behavior and Ces…0Smoking Behavior and Cessation: 0 fractional works
Molecular BiologyNeurologyPhysiology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nicotinic Acetylcholine Receptors Study Molecular Biology 0 works
  2. 2 Vagus Nerve Stimulation Research Neurology 0 works
  3. 3 Smoking Behavior and Cessation Physiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.3%not open66.7%

World: 28% of research is openly available.

Other research institutions in New Brunswick

All research institutions in New Brunswick

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.